SecSonar.com

ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

ANI Pharmaceuticals, Inc. (ANIP) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $1.8B. Revenue grew 43.8% year-over-year and the company generated $171.4M in free cash flow. This page tracks ANIP's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 897 employees · IPO May 5, 2000

Valuation

Valuation & price

$78.01 · as of May 17, 2026 · -21.1% vs 52w high

21.1

P/E ratio

Latest-FY diluted EPS

3.33

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$98.73$81.04$63.35Jul 25Dec 25Jul 26Jul 7, 25$64.91Jul 9, 25$65.31Jul 11, 25$64.96Jul 15, 25$64.00Jul 17, 25$68.04Jul 21, 25$65.41Jul 23, 25$66.90Jul 25, 25$67.48Jul 29, 25$64.20Jul 31, 25$63.35Aug 4, 25$65.43Aug 6, 25$69.09Aug 11, 25$84.88Aug 13, 25$88.74Aug 15, 25$87.47Aug 19, 25$90.12Aug 21, 25$91.14Aug 25, 25$90.32Aug 27, 25$91.88Aug 29, 25$93.50Sep 3, 25$94.92Sep 5, 25$95.35Sep 9, 25$98.46Sep 11, 25$98.73Sep 16, 25$97.55Sep 18, 25$97.48Sep 22, 25$95.93Sep 24, 25$94.99Sep 26, 25$93.05Sep 30, 25$91.60Oct 2, 25$89.13Oct 6, 25$92.06Oct 8, 25$91.65Oct 10, 25$89.79Oct 14, 25$88.74Oct 16, 25$91.95Oct 21, 25$95.38Oct 23, 25$94.90Oct 27, 25$92.86Oct 29, 25$92.23Oct 31, 25$90.60Nov 4, 25$94.48Nov 6, 25$90.23Nov 10, 25$88.93Nov 12, 25$87.27Nov 14, 25$84.02Nov 18, 25$81.07Nov 20, 25$78.52Nov 25, 25$83.22Nov 28, 25$84.85Dec 2, 25$82.12Dec 4, 25$82.74Dec 8, 25$81.34Dec 10, 25$82.03Dec 12, 25$80.39Dec 16, 25$81.10Dec 18, 25$82.83Dec 22, 25$80.72Dec 24, 25$82.18Dec 29, 25$81.38Jan 2, 26$78.43Jan 6, 26$77.48Jan 8, 26$81.04Jan 12, 26$84.35Jan 14, 26$85.03Jan 16, 26$84.83Jan 21, 26$85.52Jan 23, 26$82.99Jan 27, 26$80.45Jan 29, 26$82.00Feb 2, 26$80.00Feb 4, 26$81.27Feb 9, 26$80.34Feb 11, 26$76.25Feb 13, 26$77.36Feb 18, 26$77.81Feb 20, 26$77.77Feb 24, 26$76.70Feb 26, 26$77.15Mar 2, 26$75.22Mar 4, 26$76.53Mar 6, 26$74.04Mar 10, 26$75.96Mar 12, 26$72.49Mar 17, 26$74.28Mar 19, 26$74.82Mar 23, 26$73.92Mar 25, 26$74.07Mar 27, 26$72.82Mar 31, 26$76.90Apr 2, 26$74.21Apr 7, 26$79.47Apr 9, 26$80.14Apr 13, 26$78.31Apr 15, 26$76.48Apr 17, 26$80.92Apr 22, 26$80.14Apr 24, 26$78.64Apr 28, 26$78.50Apr 30, 26$79.45May 4, 26$82.32May 6, 26$84.06May 8, 26$81.86May 12, 26$79.50May 14, 26$79.58May 18, 26$79.34May 20, 26$82.00May 22, 26$82.72May 28, 26$81.11Jun 1, 26$76.71Jun 3, 26$75.23Jun 5, 26$81.11Jun 9, 26$81.20Jun 11, 26$81.65Jun 15, 26$82.29Jun 17, 26$80.52Jun 22, 26$80.58Jun 24, 26$82.72Jun 26, 26$84.50Jul 2, 26$86.03
$63.3552-week range$98.81
Loading valuation history…

Fundamentals

Key fundamentals

$1.8B

Market cap

43.8%

Revenue growth (YoY)

51.0%

Gross margin

$171.4M

Free cash flow (USD)

$39.6M

Net debt

3.8%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$128.6MFY 2017$176.8MFY 2018$201.6MFY 2019$206.5MFY 2020$208.5MFY 2021$216.1MFY 2022$316.4MFY 2023$486.8MFY 2024$614.4MFY 2025$883.4M
$128.6M$883.4M

Free cash flow by year

2016 → 2025

FY 2016$-121.6MFY 2017$-68.6MFY 2018$56.2MFY 2019$18.1MFY 2020$-53.1MFY 2021$-20.3MFY 2022$-47.7MFY 2023$100.4MFY 2024$47.1MFY 2025$171.4M
-$121.6M$171.4M

Gross margin by year

2021 → 2025

FY 202153.5%FY 202256.1%FY 202362.7%FY 202459.3%FY 202551.0%
53.5%51.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $240K · 10b5-1 PlanCAREY STEPHEN P. · SVP & CFO · $239.7KJun 30, 2026Filing
  • 8-K eventStock Incentive Plan AmendmentMay 21, 2026Filing
  • 8-K eventCorporate PresentationMay 13, 2026Filing
  • 8-K eventEarnings ReleaseMay 8, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing
  • 8-K eventAccounting Firm ChangeApr 7, 2026Filing

Questions

Frequently asked questions

What is ANI Pharmaceuticals, Inc.'s market cap?

ANI Pharmaceuticals, Inc. (ANIP) has a market capitalization of $1.8B.

What is ANIP's P/E ratio?

ANIP trades at a price-to-earnings ratio of 21.1, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is ANIP's price-to-book (P/B) ratio?

ANIP trades at 3.33 times book value per share.

Are insiders buying ANIP stock?

SEC Form 4 filings show no open-market insider buys at ANI Pharmaceuticals, Inc. in the last 90 days (1 sell).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

BHC

Bausch Health Companies Inc.

$2B

HCM

HUTCHMED (China) Limited

$2B

PRGO

Perrigo Company plc

$1.6B

HROW

Harrow Health, Inc.

$1.3B

PAHC

Phibro Animal Health Corporation

$1.3B

EVO

Evotec SE

$1.1B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.